For thousands of years, indigenous societies in Mexico and Central America have used psychedelics for medicinal, spiritual, and cultural purposes.
With an explosion in research looking at psychedelic therapy for a number of mental health conditions, FDA approval for MDMA-assisted psychotherapy for PTSD is anticipated for...
A donation of $1.5 million has been gifted to the UC San Diego Psychedelics and Health Research Initiative to research DMT by philanthropist Eugene Jhong.
Until now, it has been commonly thought that selective serotonin reuptake inhibitors (SSRIs) could interfere with the therapeutic potential of psilocybin treatment.
A group of experts has published a paper in the American Journal of Psychiatry examining the definition of “psychedelic-assisted psychotherapy” using psilocybin.
At PSYCH Symposium in the British Museum on 6 July a conversation between Professor Robin Carhart-Harris and journalist Kate Spicer explored the impact of psychedelic research...
In what marks a positive development for patient access to psychedelic therapies in the US, the American Medical Association has released the language of its first-ever...
In light of clinical research showing MDMA-assisted therapy as a potential treatment for PTSD, at PSYCH Symposium in the British Museum on 6 July a conversation...
At PSYCH Symposium in the British Museum on 6 July, the panel ‘Neuroimaging & Psychedelics: The Past, Present & Future’ explored how neuroimaging can inform our...
PSYCH Symposium’s afternoon panels saw discussions continue the exploration of the landscape of psychedelic healthcare.
PSYCH Symposium returned at the British Museum on 6 July to explore how psychedelic medicines can innovate healthcare – from mental health to eating disorders and...
PSYCH Symposium: London 2023 brought together key stakeholders to explore the landscape of psychedelic medicine at the British Museum on Thursday, 6 July.